Clinical monitoring VRC 200/900 POP: 6/24/19 - 6/23/22
Ended Awarded Last action
- Contract number
- 75N93019F00133
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $98,710
Award facts
- Opportunity
-
- NIHAO2017058 Solicitation number
- Vaccine Research Center Clinical Monitoring Initiative Award Notice · Posted Dec 8, 2016
- Vaccine Research Center Clinical Site Monitoring Services Initiative Award Notice · Posted Nov 17, 2016
- Contract value 79% obligated
-
- $98,709.98 Current, with exercised options
- $124,233.98 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $10,487 | |
| Original award | $88,223 |
About this award
This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to The Emmes Company LLC, a global clinical research organization. The contract is part of the Vaccine Research Center (VRC) Clinical Monitoring Initiative 2017-2024, a large multiple-award contract vehicle.
The contract provides clinical monitoring services for VRC research projects, with a period of performance from June 24, 2019 to June 23, 2022 and a potential value of $124,233.98. The Emmes Company, as the prime contractor, will provide a range of clinical trial support services including data management, statistical analysis, and safety monitoring for NIH studies related to vaccine development and infectious disease research. This contract was awarded without a small business set-aside.
Quick answers
Who was awarded contract 75N93019F00133?
75N93019F00133 was awarded to The Emmes Company, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 21, 2019.
How much is contract 75N93019F00133 worth?
The government has obligated $98,710 on 75N93019F00133. Its potential value, with all options, is $124,234.
Is contract 75N93019F00133 an order under another contract?
Yes. 75N93019F00133 is a delivery order under HHSN272201700051I, an indefinite delivery contract, on VRC Clinical Monitoring Initiative 2017-2024.
Was contract 75N93019F00133 competed?
The extent of competition for 75N93019F00133 was full and open competition after exclusion of sources. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award